Percorso di navigazione

Altri strumenti



    Profilo del soggetto registrato

GlaxoSmithKline

Numero di identificazione nel Registro: 7990322925-77
Data d'iscrizione: 06/01/2009 16:12:35

Le informazioni su questo soggetto sono state modificate il: 15/06/2015 10:39:45
Data dell'ultimo aggiornamento annuale: 27/04/2015 10:18:31
Prossimo aggiornamento previsto al più tardi il: 27/04/2016

    Entità registrata: organizzazione o lavoratore autonomo

GlaxoSmithKline

GSK

Corporation

    Categoria di registrazione

II - Lobbisti interni e associazioni di categoria, commerciali e professionali

Imprese e gruppi

    Recapito

Great West Road, 980
TW8 9GS Brentford, Middlesex
REGNO UNITO

(+44)20 8047 5000

Avenue des Arts 46/b9
1000 Brussels
BELGIO

(+32)2 282 40 55

    Responsabile legale

Signor  Andrew Witty

Chief Executive Officer

    Responsabile delle relazioni con l’UE

Signora  Sue Middleton

Vice President European Government Affairs

    Obiettivi e compiti

GSK is a science-led global healthcare company.

Our mission is to help people do more, feel better, live longer.


We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare that can improve people’s health and well-being, ultimately helping them to live life to its fullest and contribute to the prosperity of their communities.

Our Pharmaceuticals business develops and makes medicines to treat a broad range of acute and chronic diseases. Our portfolio is made up of both patent-protected and off patent medicines and we have leading global positions in respiratory disease and HIV.

Our Vaccines business is one of the largest in the world. We have a broad portfolio of over 30 paediatric, adolescent, adult and travel vaccines. In 2014, we distributed approximately 800 million doses in 170 countries.

We develop and market a range of consumer healthcare products based on scientific innovation. We have brands in four main categories: Wellness, Oral Health, Skin Health and Nutrition. These include a number of well-known brands such as Sensodyne, Panadol and Horlicks.


We have a significant global presence with commercial operations in more than 150 countries, a network of 84 manufacturing sites in 36 countries and large R&D centres in the UK, USA, Spain, Belgium and China.

mondiale

    Attività specifiche che rientrano nell'ambito di applicazione del Registro

We follow EU initiatives, policies and legislative files related to our Pharmaceuticals, Vaccines and Consumer Healthcare businesses.

This includes topics such as R&D and clinical trials, antimicrobial resistance, data protection, pharmaceutical legislation, medical devices, trade & IP, environment, smoking cessation.

Mainly via the participation of events organized by Trade Associations and Think-Tanks.


 

No

No

EC Expert Group on Rare-Diseases (on behalf of EuropaBio)

No

No

    Numero di persone coinvolte nelle attività descritte nel riquadro precedente

100%: 0   75%: 3   50%: 3   25%: 5

11

5

The number of persons reflects the full time employment falling under the scope of the register. GSK follows the guidelines provided by EFPIA regarding this registration.

    Persone accreditate che possono accedere ai locali del Parlamento europeo

Nome Cognome Data d'inizio Data di conclusione
Christian BARACAT 29/08/2015 28/08/2016
Guilherme MONTEIRO FERREIRA BORGES DOS SANTOS 26/09/2015 25/09/2016
Gisela PAYERAS BAILLY 29/08/2015 28/08/2016
Paulus Lambertus Antonius VAN HOOF 31/07/2015 29/07/2016

    Settori di interesse

  • Affari economici e finanziari
  • Affari generali ed istituzionali
  • Aiuti umanitari
  • Allargamento
  • Ambiente
  • Commercio
  • Concorrenza
  • Consumatori
  • Dogane
  • Imprese
  • Mercato interno
  • Occupazione e affari sociali
  • Politica regionale
  • Relazioni esterne
  • Ricerca e tecnologia
  • Sanità
  • Sicurezza alimentare
  • Società dell'informazione
  • Tassazione

    Appartenenza e affiliazione

American Chamber of Commerce to the European Union (AmChamEU)
Association of the European Self-Medication Industry (AESGP)
British Chamber of Commerce in Belgium
Cosmetics Europe
EuropaBio
European Biopharmaceutical Enterprises (EBE)
European Brands Association (AIM)
European Diagnostic Manufacturers Association (EDMA)
European Federation of Pharmaceutical Industries and Associations (EFPIA)
Vaccines Europe (VE)
World Federation of Advertisers (WFA)

    Dati finanziari

01/2014  -  12/2014

>= 1.750.000 € e < 1.999.999 €

0 €

N/A

10.445.466 €

FP7-People; FP7-NMP; Horizon 2020

In 2013, GSK’s estimated costs attributable to activities covered by the Register were in the range of 600.000-700.000. While GSK maintained activities in scope of the register from 2013 to 2014, the increased figures result from vacancies and the renewed “transparency register implementing guidelines” published 21 January 2015 by the Joint Transparency Register Secretariat.
GSK followed EFPIA’s interpretation and guidance on implementing those guidelines in 2014.

    Codice di condotta

Registrandosi l'organizzazione ha sottoscritto il codice di condotta del Registro per la trasparenza.